Activated T cell therapy targeting glioblastoma cancer stem cells
Ken Miyaguchi(Cedars-Sinai Medical Center), John S. Yu(NeuroSpine Institute)
Cited by 8
Related Papers
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
|Molecular Cancer|2006|1.8k
Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma
|Cancer Research|2004|532
Hedgehog Signaling Regulates Brain Tumor-Initiating Cell Proliferation and Portends Shorter Survival for Patients with PTEN-Coexpressing Glioblastomas
|Stem Cells|2008|113
A Peroxisome Proliferator-activated Receptor-γ Agonist, Troglitazone, Facilitates Caspase-8 and -9 Activities by Increasing the Enzymatic Activity of Protein-tyrosine Phosphatase-1B on Human Glioma Cells
|Journal of Biological Chemistry|2005|67
Identification of Novel Human Leukocyte Antigen-A*0201-Restricted, Cytotoxic T Lymphocyte Epitopes on CD133 for Cancer Stem Cell Immunotherapy
|Stem Cells Translational Medicine|2013|25